Gilead Sciences (GILD) Current Assets (2009 - 2026)
Gilead Sciences' Current Assets came in at $13.95 billion for Q2 2026, down 5.3% from $14.72 billion a year earlier and down 25.2% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Current Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Gilead Sciences' Current Assets was $18.34 billion, down 4.3% from FY2024.
- Current Assets carries a five-year compound annual growth rate of 2.8% (FY2020 to FY2025).
- Going back by year, Current Assets was $19.17 billion in FY2024 (+19.2%), $16.09 billion in FY2023 (+11.4%), $14.44 billion in FY2022 (-2.2%) and $14.77 billion in FY2021 (-7.7%).
- The Q2 2026 figure represents the lowest quarterly Current Assets since Q2 2024.
- Year-over-year, Current Assets increased in five of the last eight quarters, with growth averaging 9.1%.
- The fastest year-over-year change in Current Assets over five years came in Q3 2025 (growth of 20.9%), and the weakest in Q3 2021 (a decline of 54.8%).
- Business Quant data shows GILD's Current Assets at $18.64 billion (Q1 2026), $18.34 billion (Q4 2025) and $17.87 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn | 28.58 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.95 Bn |
| Mar 31, 2026 | 18.64 Bn |
| Dec 31, 2025 | 18.34 Bn |
| Sep 30, 2025 | 17.87 Bn |
| Jun 30, 2025 | 14.72 Bn |
| Mar 31, 2025 | 16.90 Bn |
| Dec 31, 2024 | 19.17 Bn |
| Sep 30, 2024 | 14.78 Bn |
| Jun 30, 2024 | 12.32 Bn |
| Mar 31, 2024 | 14.04 Bn |
| Dec 31, 2023 | 16.09 Bn |
| Sep 30, 2023 | 15.98 Bn |
| Jun 30, 2023 | 14.29 Bn |
| Mar 31, 2023 | 13.46 Bn |
| Dec 31, 2022 | 14.44 Bn |
| Sep 30, 2022 | 13.55 Bn |
| Jun 30, 2022 | 13.18 Bn |
| Mar 31, 2022 | 12.63 Bn |
| Dec 31, 2021 | 14.77 Bn |
| Sep 30, 2021 | 13.99 Bn |
API Access
Gilead Sciences Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();